Skip to content
Tuesday, November 17, 2026
AeroJackpot

Zimbabwe Rejects ‘Unbalanced’ American Healthcare Assistance Agreement Over Information Fears

Health funding illustration
The proposed US funding would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has rejected a major American health deal worth 367 million US dollars (£272m) spanning five years over Washington's request for sensitive information.

The decision came to light following a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "skewed".

An official spokesperson has since stated that the United States was requesting genetic material for research and profit while was not willing to share the benefits from future treatments.

"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has appealed for more dialogue to secure a deal suitable to all parties so the nation's vital HIV treatment initiative can be sustained.

Wider Context

This rejection comes after a similar situation in neighbouring Kenya, where a court suspended a similar health funding agreement following concerns were filed about the security of citizens' health data.

Since returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.

The agency had administered aid for the US government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral deals to enhance openness and responsibility.

According to statements, 16 African countries have so far signed similar health pacts, representing over $18.3bn of fresh investment.

Specifics of the Rejected Deal

This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this cooperation would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy through American-funded initiatives," Tremont commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.

"Effectively, our country would supply the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our people should a new disease outbreak arise."

Sovereignty and International Frameworks

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining structures previously established via the international health agency.

Mangwana cited its Pandemic Benefit-Sharing system created to deal with potential pandemics.

"This mechanism is designed to guarantee that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."

These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We are open to ongoing discussions with our American counterparts on how future collaboration could be structured in a way that honours the independence and interests of both nations."

Medical Community Reaction

Medical experts expressed it acknowledged the government's concerns, but recommended that negotiations must proceed since much of the country's HIV programmes relied on external financing.

"Where technical issues arise, such as those relating to information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," the group commented.

The halted deal underscores the ongoing challenges between receiving crucial foreign assistance and safeguarding national sovereignty in an ever more data-driven world.

About the author

Kayla May

Maya is a commercial pilot and aviation journalist with over 15 years of experience, sharing insights on flight safety and industry trends.

AeroJackpot

Type to search articles.